Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthstream (HSTM) Shares Outstanding (Diluted Average) (2017 - 2025)

Healthstream (HSTM) has disclosed Shares Outstanding (Diluted Average) for 12 consecutive years, with $30.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) fell 1.31% to $30.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.1 million through Dec 2025, down 1.31% year-over-year, with the annual reading at $30.1 million for FY2025, 1.31% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $30.1 million at Healthstream, up from $29.8 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $31.7 million in Q3 2021, with the low at $29.8 million in Q3 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $30.8 million, with a median of $30.7 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Diluted Average) decreased 3.49% in 2022, then increased 0.67% in 2023.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $31.6 million in 2021, then decreased by 2.85% to $30.7 million in 2022, then decreased by 0.14% to $30.7 million in 2023, then fell by 0.42% to $30.5 million in 2024, then dropped by 1.31% to $30.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $30.1 million, $29.8 million, and $30.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.